BALDACCI, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 10.370
AS - Asia 4.635
EU - Europa 4.213
SA - Sud America 756
AF - Africa 273
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 20.263
Nazione #
US - Stati Uniti d'America 10.137
IT - Italia 1.564
SG - Singapore 1.540
CN - Cina 1.289
HK - Hong Kong 705
BR - Brasile 606
SE - Svezia 605
DE - Germania 524
VN - Vietnam 465
BG - Bulgaria 269
GB - Regno Unito 230
FR - Francia 206
FI - Finlandia 169
AT - Austria 166
CA - Canada 165
RU - Federazione Russa 146
TR - Turchia 119
IN - India 104
CI - Costa d'Avorio 103
JP - Giappone 84
KR - Corea 61
PL - Polonia 60
BD - Bangladesh 56
AR - Argentina 51
UA - Ucraina 50
SN - Senegal 48
NL - Olanda 40
MX - Messico 39
IQ - Iraq 36
ZA - Sudafrica 34
BE - Belgio 32
ES - Italia 31
NG - Nigeria 28
CH - Svizzera 26
VE - Venezuela 26
CZ - Repubblica Ceca 22
PK - Pakistan 22
MA - Marocco 18
SA - Arabia Saudita 18
ID - Indonesia 17
CO - Colombia 16
LT - Lituania 15
GR - Grecia 14
EC - Ecuador 13
PE - Perù 13
UZ - Uzbekistan 11
AU - Australia 10
KE - Kenya 10
PY - Paraguay 10
TW - Taiwan 10
EG - Egitto 9
IE - Irlanda 9
JM - Giamaica 9
PH - Filippine 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
IL - Israele 8
JO - Giordania 8
LB - Libano 7
MY - Malesia 7
BO - Bolivia 6
KZ - Kazakistan 6
LV - Lettonia 6
AZ - Azerbaigian 5
CL - Cile 5
PA - Panama 5
RO - Romania 5
TN - Tunisia 5
IR - Iran 4
KG - Kirghizistan 4
OM - Oman 4
TH - Thailandia 4
AL - Albania 3
ET - Etiopia 3
GE - Georgia 3
KH - Cambogia 3
MD - Moldavia 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
AM - Armenia 2
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
MN - Mongolia 2
NI - Nicaragua 2
PT - Portogallo 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
CG - Congo 1
CR - Costa Rica 1
Totale 20.239
Città #
Ashburn 1.161
Woodbridge 881
Fairfield 871
Singapore 806
San Jose 703
Hong Kong 695
Dallas 676
Santa Clara 551
Chandler 530
Ann Arbor 504
Serra 501
Houston 449
Seattle 369
Wilmington 302
Shanghai 293
Cambridge 291
Beijing 279
Sofia 267
New York 248
Milan 189
Los Angeles 186
Boardman 176
Munich 150
Vienna 150
Princeton 125
Florence 120
Frankfurt am Main 116
Ho Chi Minh City 113
Ottawa 111
Pisa 109
Lawrence 107
Abidjan 103
Lauterbourg 100
Hanoi 91
Medford 91
Hefei 82
Tokyo 80
Council Bluffs 77
Des Moines 75
Turku 75
Istanbul 61
Rome 61
São Paulo 58
Seoul 57
London 55
Buffalo 54
Lucca 50
Nanjing 50
Redondo Beach 50
San Diego 50
Dakar 48
Warsaw 48
Jacksonville 47
Dearborn 43
Bremen 42
Dong Ket 39
Chicago 36
Orem 34
Boulder 31
Brussels 30
Helsinki 28
Lagos 27
Norwalk 27
Izmir 26
Paris 26
Ogden 25
Nuremberg 24
Washington 24
Belo Horizonte 23
Nanchang 23
Redwood City 23
Rio de Janeiro 22
Montreal 21
The Dalles 21
Shenyang 20
Fuzhou 19
Kunming 19
Chennai 18
Da Nang 18
Johannesburg 18
Lancaster 18
Phoenix 18
Baghdad 17
Denver 16
Guangzhou 16
Bern 15
Fort Worth 15
Amsterdam 14
Baltimore 14
Brno 14
Columbus 14
Hebei 14
San Francisco 14
Shenzhen 14
Vicopisano 14
Atlanta 13
Brasília 13
Brooklyn 13
Düsseldorf 13
Haiphong 13
Totale 14.491
Nome #
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 335
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 303
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 271
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 269
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 268
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 238
Spontaneous bilateral carotid artery dissection and hereditary haemochromatosis: what relationship? 236
Occurrence of seizures and EEG interictal epileptiform discharges in AD patients and their correlation with clinical features: a cross-sectional study 233
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 232
Epilepsy occurrence in patients with Alzheimer's disease: clinical experience in a tertiary dementia center 219
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 219
Sexual headache: two familiar orgasmic headache cases and review of the literature. 215
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 212
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 212
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. 209
Increase in Mitochondrial D-Loop Region Methylation Levels in Mild Cognitive Impairment Individuals 206
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 205
Postpartum headache due to spontaneous cervical artery dissection 198
Recanalization and pseudoaneurism during spontaneous cervical artery dissection follow-up 197
Brain metabolic correlates of Locus Coeruleus degeneration in Alzheimer's disease: a multimodal neuroimaging study 194
Chronic Migraine with Medication Overuse and OnabotulinumtoxinA: Two Positive Case Reports of a Modified Injection Protocol 194
Apolipoprotein E Polymorphism and Oxidative Stress in Human Peripheral Blood Cells: Can Physical Activity Reactivate the Proteasome System through Epigenetic Mechanisms? 194
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 188
Evidences of Reduced Antioxidant Activity in Patients with Chronic Migraine and Medication-Overuse Headache 187
Cerebellar ataxia with complete clinical recovery and resolution of MRI lesions related to central pontine myelinolysis: case report and literature review 186
The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study 182
Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study. 182
A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs. 178
Impact of ApoE Polymorphism and Physical Activity on Plasma Antioxidant Capability and Erythrocyte Membranes 177
Preferential occurrence of attacks during night sleep and/or upon awakening negatively affects migraine clinical presentation 176
Donepezil improves vascular function in a mouse model of Alzheimer's disease 176
Oxidative stress assessment in Alzheimer's disease: a clinic setting study 175
Migraine features in migraineurs with and without anxiety-depression symptoms: A hospital-based study 174
Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. 173
Vertebrobasilar recording with contrast transcranial Doppler in right-to-left shunt diagnosis 171
SUNA syndrome with seasonal pattern 170
Localized calcific hematoma of the scalp presenting as a nummular-like headache: a case report. 170
Nummular headache dramatically responsive to indomethacin 167
Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers 165
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 165
Inflammation and neurodegeneration plasmatic biomarkers in patients with obstructive sleep apnea syndrome and mild cognitive impairment 163
Prevalence of right-to-left shunt in patients with cluster headache 160
Fatigue, sleep-wake pattern, depressive and anxiety symptoms and body-mass index: analysis in a sample of episodic and chronic migraine patients 160
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases 160
Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology 159
Comparison of plasmatic interleukins patterns among cognitively unimpaired subjects, patients affected by mild cognitive impairment and subjects with Alzheimer's disease dementia 156
Triggers in allodynic and non-allodynic migraineurs. A clinic setting study. 155
Long-term beneficial impact of the randomised trial 'Train the Brain', a motor/cognitive intervention in mild cognitive impairment people: effects at the 14-month follow-up 154
Biological determinants of blood-based cytokines in the Alzheimer's Disease clinical continuum 153
Dissecting the Interplay between Time of Dementia and Cognitive Profiles in Lewy Body Dementias 153
Beyond Pain Relief: Unveiling the Multifaceted Impact of Anti-CGRP/R mAbs on Comorbid Symptoms in Resistant Migraine Patients 151
Spontaneous Dorsal Extramedullary Hematoma: A Rare Case Presenting as Isolated Thunderclap Headache 151
Plasma levels of oxidative stress markers, before and after BoNT/A Treatment, in chronic migraine 150
Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments 150
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40 149
Locus Coeruleus magnetic resonance imaging in cognitively intact elderly subjects 149
Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases 147
Biomarker-guided clustering of Alzheimer's disease clinical syndromes 147
Reliability of administrative data for the identification of Parkinson's disease cohorts. 146
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development 146
Impact of COVID-19 pandemic on cognition in Parkinson's disease 146
Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD 145
Plasmatic biomarkers of inflammation and neurodegeneration in patients with Obstructive Sleep Apnea Syndrome and Mild Cognitive Impairment 144
"INDOTEST" in atypical hemicrania continua 144
Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer’s Disease 144
Cerebrospinal fluid neurogranin as a biomarker of neurodegenerative diseases: A cross-sectional study 142
A frontline defense against neurodegenerative diseases:the development of early disease detection methods 142
A case of idiopathic low CSF pressure headache presenting as cough headache. 141
Clinical features associated with ictal osmophobia in migraine. 141
α-synuclein as an emerging pathophysiological biomarker of Alzheimer's disease 140
Plasmatic biomarkers of inflammation and neurodegeneration in patients with Obstructive Sleep Apnea Syndrome and Mild Cognitive Impairment 138
'Airlplane headache' with aura 138
Dopamine agonist modifies cortical activity in Parkinson disease: a functional neuroimaging study. 138
Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia 137
MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints 137
Precision pharmacology for Alzheimer's disease 137
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease 137
Mitochondrial d-loop region methylation and copy number in peripheral blood dna of parkinson’s disease patients 137
Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment. 136
Head tremor as a warning symptom of rapidly progressive syringomyelia: a case report 136
Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases 135
Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence 135
Mild Behavioral Impairment in Psychogeriatric Patients: Clinical Features and Psychopathology Severity 134
Biomarker-guided classification scheme of neurodegenerative diseases 134
Cognitive correlates of negative symptoms in behavioral variant frontotemporal dementia: implications for the frontal lobe syndrome. 132
Levodopa response in dementia with lewy bodies: a 1-year follow-up study. 131
Blood-Based Biomarker Screening with Agnostic Biological Definitions for an Accurate Diagnosis Within the Dimensional Spectrum of Neurodegenerative Diseases 131
Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease 130
How aware are migraineurs of their triggers? 127
Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease 126
Plasmatic biomarkers of inflammation and neurodegeneration in patients with Obstructive Sleep Apnea Syndrome and Mild Cognitive Impairment 125
null 125
Pre-existing frontal lobe dysfunction signs as predictors of subsequent neurotoxicity in CAR T cell therapy: insights from a case series 124
Plasmatic biomarkers of inflammation and neurodegeneration in patients with Obstructive Sleep Apnea Syndrome and Mild Cognitive Impairment 124
Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer’s and other neurodegenerative diseases 124
Progressive impairment of decision-making in behavioral-variant frontotemporal dementia. 123
Future avenues for Alzheimer's disease detection and therapy: Liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery 123
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results 121
Concomitant development of hypersexuality and delusional jealousy in patients with Parkinson's disease: A case series. 120
Paroxysmal exertion-induced dystonia secondary to Erdheim-Chester disease. 120
Totale 16.624
Categoria #
all - tutte 59.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.751


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021188 0 0 0 0 0 0 0 0 0 0 68 120
2021/20221.245 17 42 34 70 257 145 38 81 78 41 107 335
2022/20232.023 208 273 175 159 197 230 18 142 397 13 152 59
2023/20241.412 127 132 171 101 185 251 91 46 14 30 95 169
2024/20254.354 40 150 109 268 404 440 371 218 440 503 498 913
2025/20265.584 430 699 716 584 616 426 899 278 310 617 9 0
Totale 20.590